TICKVALE
>⌘K
NYSE · CIK 0000059478 · PHARMACEUTICAL PREPARATIONS

ELI LILLY AND COMPANY

LLY chart by TradingView
P/E 40.1xP/B 31.6xP/SALES 13.5xEV/EBITDA FCF YIELD

PRICE HISTORY

LIVE · NYSE
LLY chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$65.2B
EBITDA
FREE CASH FLOW
EPS
$22.95
GROSS MARGIN
83.04%
ROIC
33.41%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

40.1x
+15%
LATEST · Q2 FY26
40.1xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
12.9x244.7x

P / SALES (TTM)

13.5x
+229%
LATEST · Q2 FY26
13.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.7x21.0x

P / BOOK

31.6x
+479%
LATEST · Q2 FY26
31.6xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
5.5x60.4x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

14.0x
+221%
LATEST · Q2 FY26
14.0xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.9x21.7x

FCF YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$23.0B
+343%
LATEST · Q2 FY26
23.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$7.1B
+812%
LATEST · Q2 FY26
7.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$7.94
+982%
LATEST · Q2 FY26
7.94Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

47.67%
+43.0pp
LATEST · Q2 FY26
47.67%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-43.35%61.19%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

+20.9pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.11%40.25%

RETURN ON CAPITAL

33.46%
+22.1pp
LATEST · Q2 FY26
33.46%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-1.09%53.37%

RETURN ON EQUITY (TTM)

78.84%
+63.2pp
LATEST · Q2 FY26
78.84%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-1.76%319.09%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN85.78%
OPERATING MARGIN
NET MARGIN30.88%
FCF MARGIN
99.4358.4717.50-23.47-64.43GROSSNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

+1387%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.2B
+227%
LATEST · Q2 FY26
0.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

+203%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.89B
-16%
LATEST · Q2 FY26
0.89BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$3.46
+206%
LATEST · Q2 FY26
3.46Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$8.9B
+157%
LATEST · Q2 FY26
8.9BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$54.9B
+487%
LATEST · Q2 FY26
54.9BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 85.39%INSIDERS 0.15%OTHER / RETAIL 14.46%5,735 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Lilly Endowment, Inc9.60%90.4M$107.16B-1.7%
Blackrock Inc.7.05%66.4M$78.71B-0.6%
Vanguard Capital Management LLC5.67%53.4M$63.27BNEW
PNC Financial Services Group, Inc.5.45%51.3M$60.86B-0.0%
State Street Corporation3.78%35.6M$42.22B+0.7%
FMR, LLC2.80%26.3M$31.23B+2.4%
Capital Research Global Investors2.62%24.6M$29.21B+0.3%
Vanguard Portfolio Management LLC2.23%21.0M$24.87BNEW
Geode Capital Management, LLC2.14%20.2M$23.94B+1.9%
Capital World Investors1.66%15.6M$18.52B+3.9%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.